Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204243200 on October 24, 2002

J. Biol. Chem., Vol. 278, Issue 2, 1005-1011, January 10, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
278/2/1005    most recent
M204243200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Somerville, L.
Right arrow Articles by Kriwacki, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Somerville, L.
Right arrow Articles by Kriwacki, R. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structure and Dynamics of Thioguanine-modified Duplex DNA*,

Lilla SomervilleDagger §, Eugene Y. KrynetskiDagger §, Natalia F. KrynetskaiaDagger §, Richard D. Beger, Weixing Zhang||, Craig A. Marhefka**, William E. EvansDagger §Dagger Dagger , and Richard W. Kriwacki||§§¶¶

From the Departments of Dagger  Pharmaceutical Sciences and || Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, the Departments of ** Pharmaceutical Sciences, § Clinical Pharmacy, and §§ Molecular Sciences, Health Sciences Center, University of Tennessee, Memphis, Tennessee 38163, and the  Division of Chemistry, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, Arkansas 72079

Mercaptopurine and thioguanine, two of the most widely used antileukemic agents, exert their cytotoxic, therapeutic effects by being incorporated into DNA as deoxy-6-thioguanosine. However, the molecular mechanism(s) by which incorporation of these thiopurines into DNA translates into cytotoxicity is unknown. The solution structure of thioguanine-modified duplex DNA presented here shows that the effects of the modification on DNA structure were subtle and localized to the modified base pair. Specifically, thioguanine existed in the keto form, formed weakened Watson-Crick hydrogen bonds with cytosine and caused a modest ~10° opening of the modified base pair toward the major groove. In contrast, thioguanine significantly altered base pair dynamics, causing an ~80-fold decrease in the base pair lifetime with cytosine compared with normal guanine. This perturbation was consistent with the ~6 °C decrease in DNA melting temperature of the modified oligonucleotide, the 1.13 ppm upfield shift of the thioguanine imino proton resonance, and the large increase in the exchange rate of the thioguanine imino proton with water. Our studies provide new mechanistic insight into the effects of thioguanine incorporation into DNA at the level of DNA structure and dynamics, provide explanations for the effects of thioguanine incorporation on the activity of DNA-processing enzymes, and provide a molecular basis for the specific recognition of thioguanine-substituted sites by proteins. These combined effects likely cooperate to produce the cellular responses that underlie the therapeutic effects of thiopurines.


* This research was supported by American Lebanese Syrian Associated Charities (ALSAC), a Cancer Center (CORE) Support Grant (CA 21765), The American Cancer Society, and the NCI, National Institutes of Health Grant R37 CA36401.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figures 1-3 titled Intrastrand and sequential connectivities between H-1' and H-6/H-8 protons, Comparison of experimental and back-calculated NMR spectra, and Comparison of one-dimensional 31P spectra, respectively.

The atomic coordinates and structure factors (1N14 and 1N17 for the G-C and thioG-C DNA duplexes, respectively) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

Dagger Dagger To whom correspondence may be addressed: Dept. of Pharmaceutical Sciences, St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105. Tel.: 901-495-3663; Fax: 901-495-6869; E-mail: William.Evans@stjude.org.

¶¶ To whom correspondence may be addressed: Dept. of Structural Biology, St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105. Tel.: 901-495-3290; Fax: 901-495-3032; E-mail: Richard.Kriwacki@stjude.org.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
N. F. Krynetskaia, M. S. Phadke, S. H. Jadhav, and E. Y. Krynetskiy
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Mol. Cancer Ther., April 1, 2009; 8(4): 864 - 872.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Lahoud, V. Timoshchuk, A. Lebedev, K. Arar, Y.-M. Hou, and H. Gamper
Properties of pseudo-complementary DNA substituted with weakly pairing analogs of guanine or cytosine
Nucleic Acids Res., December 1, 2008; 36(22): 6999 - 7008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Krynetskaia, H. Xie, S. Vucetic, Z. Obradovic, and E. Krynetskiy
High Mobility Group Protein B1 Is an Activator of Apoptotic Response to Antimetabolite Drugs
Mol. Pharmacol., January 1, 2008; 73(1): 260 - 269.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Gu and Y. Wang
In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine
Nucleic Acids Res., June 28, 2007; 35(11): 3693 - 3704.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Bohon and C. R. de los Santos
Effect of 6-thioguanine on the stability of duplex DNA
Nucleic Acids Res., May 19, 2005; 33(9): 2880 - 2886.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. F. Krynetskaia, T. L. Brenner, E. Y. Krynetski, W. Du, J. C. Panetta, P. Ching-Hon, and W. E. Evans
Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-/- Mice
Mol. Pharmacol., August 1, 2003; 64(2): 456 - 465.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Bohon and C. R. de los Santos
Structural effect of the anticancer agent 6-thioguanine on duplex DNA
Nucleic Acids Res., February 15, 2003; 31(4): 1331 - 1338.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
W. L. Carroll, D. Bhojwani, D.-J. Min, E. Raetz, M. Relling, S. Davies, J. R. Downing, C. L. Willman, and J. C. Reed
Pediatric Acute Lymphoblastic Leukemia
Hematology, January 1, 2003; 2003(1): 102 - 131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement